dpp 4 inhibitors and glp 1 agonists together DPP-4 GLP-1RAs: cardiovascular safety and benefits | Military Medical Research Dipeptidyl Peptidase-4 Inhibitors: A Systematic

The cohort study from the University of Oxford (n 100,000) showed a 48% lower risk of dementia among semaglutide users compared to those treated with sitagliptin

GLP-1 medications, such as Ozempic , mimic these natural effects to help with weight loss and blood sugar control

These have also been shown to promote weight loss in overweight/obese individuals with diabetes

Lancet Neurol 2016;15:78-91

Progress typically builds over several months, and as with any medical weight-loss plan, the results can vary from patient to patient and depend on consistency, lifestyle changes, and dosage

doi: 10.1210/clinem/dgab722 38 WillardFSDourosJDGabeMBShowalterADWainscottDBSuterTMet al